VanEck Biotech ETF (NASDAQ:BBH) Trading Up 0.6% – Should You Buy?

VanEck Biotech ETF (NASDAQ:BBH) shares rose 0.6% during mid-day trading on Tuesday . The stock traded as high as $212.54 and last traded at $211.57. 5,331 shares traded hands during trading, an increase of 5% from the average daily volume of 5,064 shares. The stock had previously closed at $210.33.

VanEck Biotech ETF Stock Up 0.6%

The stock has a 50 day simple moving average of $189.75 and a 200 day simple moving average of $191.16.

Institutional Trading of VanEck Biotech ETF

A number of large investors have recently modified their holdings of the company. Empowered Funds LLC bought a new stake in VanEck Biotech ETF in the 4th quarter valued at about $38,000. Flagship Harbor Advisors LLC acquired a new stake in shares of VanEck Biotech ETF in the 4th quarter worth approximately $47,000. Allworth Financial LP lifted its position in VanEck Biotech ETF by 255.0% in the fourth quarter. Allworth Financial LP now owns 426 shares of the company’s stock worth $81,000 after purchasing an additional 306 shares during the period. Fifth Third Bancorp acquired a new stake in shares of VanEck Biotech ETF in the first quarter valued at $127,000. Finally, Huntington National Bank acquired a new stake in VanEck Biotech ETF in the 4th quarter valued at about $132,000. Institutional investors and hedge funds own 32.05% of the company’s stock.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.